3.1. Study Participants
Among the 73 eligible patients enrolled in the study, 21 were excluded, and two were lost to follow-up in the ESP block group. Finally, 50 patients completed the study, including 24 in the ESP block group and 26 in the control group (The demographic data of the two groups are compared in 